Secondary analysis of APPLE study suggests atorvastatin may reduce atherosclerosis progression in pubertal lupus patients with higher C reactive protein

Annals of the Rheumatic Diseases

Volumn 73, Issue 3, 2014, Pages 557-566

  Ardoin, Stacy P ^a   Schanberg, Laura Eve ^b   Sandborg, Christy I ^c   Barnhart, Huiman X ^b   Evans, Greg W ^d   Yow, Eric ^b   Mieszkalski, Kelly L ^b   Ilowite, Norman T ^e   Eberhard, Anne ^f   Imundo, Lisa F ^g   Kimura, Yuki ^h   Levy, Deborah ⁱ   Von Scheven, Emily ^j   Silverman, Earl ⁱ   Bowyer, Suzanne L ^w   Punaro, L ^k   Singer, Nora G ^l   Sherry, David D ^m   McCurdy, Deborah K ⁿ   Klein Gitelman, Marissa ^o   Wallace, Carol ^p   Silver, Richard M ^q   Wagner Weiner, Linda ^r   Higgins, Gloria C ^a   Brunner, Hermine I ^s   Jung, Lawrence ^t   Soep, Jennifer B ^u   Reed, Ann M ^v   Thompson, Susan D ^s   more..

^a OHIO STATE UNIVERSITY   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^f Northwell Health   (United States)

^g NewYork Presbyterian Hospital   (United States)

^h HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

ⁱ HOSPITAL FOR SICK CHILDREN   (Canada)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k TEXAS SCOTTISH RITE HOSPITAL FOR CHILDREN   (United States)

^l UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^m CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

ⁿ UNIVERSITY OF CALIFORNIA   (United States)

^o NORTHWESTERN UNIVERSITY   (United States)

^p SEATTLE CHILDREN S HOSPITAL   (United States)

^q MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^r UNIVERSITY OF CHICAGO   (United States)

^s CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^t CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^u CHILDREN S HOSPITAL   (United States)

^v MAYO CLINIC   (United States)

^w NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

ATHEROSCLEROSIS; AUTOIMMUNE DISEASES; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; AGE FACTORS; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CAROTID ARTERIES; CAROTID INTIMA-MEDIA THICKNESS; CHOLESTEROL, LDL; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; FEMALE; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; PROSPECTIVE STUDIES; PUBERTY; PYRROLES; TREATMENT OUTCOME;

EID: 84893770714     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2012-202315     Document Type: Article

References (40)

1. Urowitz MB, Gladman D, Ibanez D, et al. Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosus. Arthritis Care Res (Hoboken) 2010;62:881-7.
2. Manzi S, Meilahn EN, Rairie JE, et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 1997;145:408-15. (Pubitemid 27084212)
3. Roman MJ, Shanker BA, Davis A, et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003;349:2399-406. (Pubitemid 37542988)
4. Roman MJ, Crow MK, Lockshin MD, et al. Rate and determinants of progression of atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 2007;56:3412-19. (Pubitemid 47585436)
5. Manzi S, Selzer F, Sutton-Tyrrell K, et al. Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus. Arthritis Rheum 1999;42:51-60. (Pubitemid 29042570)
6. Brugts JJ, Yetgin T, Hoeks SE, et al. The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials. BMJ 2009;338:b2376.
7. Baigent C, Keech A, Kearney PM, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins. Lancet 2005;366:1267-78.
8. Blum A, Shamburek R. The pleiotropic effects of statins on endothelial function, vascular inflammation, immunomodulation and thrombogenesis. Atherosclerosis 2009;203:325-30.
9. Petri MA, Kiani AN, Post W, et al. Lupus Atherosclerosis Prevention Study (LAPS). Ann Rheum Dis 2011;70:760-5.
10. Schanberg LE, Sandborg C, Barnhart HX, et al. Use of atorvastatin in systemic lupus erythematosus in children and adolescents. Arthritis Rheum 2012; 64:285-96.
11. Plazak W, Gryga K, Dziedzic H, et al. Influence of atorvastatin on coronary calcifications and myocardial perfusion defects in systemic lupus erythematosus patients: a prospective, randomized, double-masked, placebo-controlled study. Arthritis Res Ther 2011;13:R117.
12. Stary HC. Evolution and progression of atherosclerotic lesions in coronary arteries of children and young adults. Arteriosclerosis 1989;9:I19-32. (Pubitemid 19046963)
13. Stary HC. Macrophages, macrophage foam cells, and eccentric intimal thickening in the coronary arteries of young children. Atherosclerosis 1987;64:91-108. (Pubitemid 17047149)
14. Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008;359:2195-207.
15. Schanberg LE, Sandborg C, Barnhart HX, et al. Premature atherosclerosis in pediatric systemic lupus erythematosus: risk factors for increased carotid intima-media thickness in the atherosclerosis prevention in pediatric lupus erythematosus cohort. Arthritis Rheum 2009;60:1496-507.
16. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
17. Buyon JP, Petri MA, Kim MY, et al. The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial. Ann Intern Med 2005;142:953-62.
18. Gladman D, Ginzler E, Goldsmith C, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996;39:363-9. (Pubitemid 26085211)
19. Varni JW, Seid M, Rode CA. The PedsQL: measurement model for the pediatric quality of life inventory. Med Care 1999;37:126-39.
20. Varni JW, FAU - Seid M, Seid M, et al. The PedsQL in pediatric rheumatology: reliability, validity, and responsiveness of the Pediatric Quality of Life Inventory Generic Core Scales and Rheumatology Module. Arthritis Rheum 2002;46:714-25. (Pubitemid 34214252)
21. Ardoin SP, Schanberg LE, Sandborg C, et al. Laboratory markers of cardiovascular risk in pediatric SLE: the APPLE baseline cohort. Lupus 2010;19:1315-25.
22. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003;107:363-9. (Pubitemid 36158034)
23. Schlossberger NM, Turner RA, Irwin CE Jr. Validity of self-report of pubertal maturation in early adolescents. J Adolesc Health 1992;13:109-13.
24. Anonymous National Cholesterol Education Program (NCEP): highlights of the report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Pediatrics 1992;89:495-501.
25. Ford ES, Giles WH, Myers GL, et al. C-reactive protein concentration distribution among US children and young adults: findings from the National Health and Nutrition Examination Survey, 1999-2000. Clin Chem 2003;49:1353-7. (Pubitemid 36900622)
26. Chambless LE, Heiss G, Folsom AR, et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol 1997;146:483-94. (Pubitemid 27391409)
27. Bots ML, Evans GW, Riley WA, et al. Carotid intima-media thickness measurements in intervention studies: design options, progression rates, and sample size considerations: a point of view. Stroke 2003;34:2985-94. (Pubitemid 37517782)
28. Bots ML, Hoes AW, Koudstaal PJ, et al. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 1997;96:1432-7. (Pubitemid 27375333)
29. O'Leary DH, Polak JF, Kronmal RA, et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999;340:14-22. (Pubitemid 29024679)
30. Hansen F, FAU - Mangell P, Mangell P, et al. Diameter and compliance in the human common carotid artery - variations with age and sex. Ultrasound Med Biol 1995;21:1-9.
31. Sass C, Herbeth B, Chapet O, et al. Intima-media thickness and diameter of carotid and femoral arteries in children, adolescents and adults from the Stanislas cohort: effect of age, sex, anthropometry and blood pressure. J Hypertens 1998;16:1593-602. (Pubitemid 28515485)
32. Dalla Pozza R, Beyerlein A, Thilmany C, et al. The effect of cardiovascular risk factors on the longitudinal evolution of the carotid intima medial thickness in children with type 1 diabetes mellitus. Cardiovasc Diabetol 2011;10:53.
33. Wiegman A, de Groot E, Hutten BA, et al. Arterial intima-media thickness in children heterozygous for familial hypercholesterolaemia. Lancet 2004;363:369-70. (Pubitemid 38169546)
34. Wiegman A, Hutten BA, de Groot E, et al. Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial. JAMA 2004;292:331-7. (Pubitemid 38944256)
35. Petri M. Sex hormones and systemic lupus erythematosus. Lupus 2008;17:412-15. (Pubitemid 351798718)
36. Emberson J, Bennett D, Link E, et al. C-reactive protein concentration and the vascular benefits of statin therapy: an analysis of 20 536 patients in the Heart Protection Study. Lancet 2011;377:469-76.
37. Nguyen QM, Toprak A, Xu JH, et al. Progression of segment-specific carotid artery intima-media thickness in young adults (from the Bogalusa Heart Study). Am J Cardiol 2011;107:114-19.
38. Bohm B, Hartmann K, Buck M, et al. Sex differences of carotid intima-media thickness in healthy children and adolescents. Atherosclerosis 2009;206:458-63.
39. Crouse JR III, Raichlen JS, Riley WA, et al. Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial. JAMA 2007;297:1344-53. (Pubitemid 46513235)
40. Nguyen QM, FAU - Toprak A, Toprak A, et al. Progression of segment-specific carotid artery intima-media thickness in young adults (from the Bogalusa Heart Study). Am J Cardiol 2011;107:114-19. Diseases